alexa Effect Of Some Psychoactive Agents On Memory In Rats With Regard To Aluminum-induced Dementia
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Pharma & Clinical Pharmacy Congress
November 07-09, 2016 Las Vegas, Nevada, USA

Abdel-Moez Assi, Raafat Abdel-Badeaa Abdel-Aal and Botros Beniamin Kostandy
Assiut University, Egypt
Posters & Accepted Abstracts: Clin Pharmacol Biopharm
DOI: 10.4172/2167-065X.C1.023
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative disorder of the brain. AD is the most common type of dementia. The major histopathological features of AD are neuritic (or ‘senile’) plaques, neurofibrillary tangles, and a loss of neurons and synapses. The degeneration of cholinergic neuronal systems, in particular those projecting from the basal forebrain to the hippocampus and cerebral cortex, is a consistent feature in the neuropathology of AD. These systems play an intrinsic role in learning and memory processes and the degree of cholinergic degeneration has been shown to correlate with the loss of cognitive function. Memory deficit is not a unitary phenomenon in AD. Up to 90% of patients with dementia develop significant behavioral problems during the course of their illness. Behavioral and psychiatric symptoms as delusions, hallucinations or agitation develop in as many as 60% of community-dwelling dementia patients. The term “behavioral and psychological symptoms of dementia” (BPSD) has been proposed to describe the spectrum of non-cognitive manifestations of dementia. Antipsychotics are frequently added to anti-Alzheimer’s therapy to control BPSD, Haloperidol and risperidone are typical and atypical antipsychotics, respectively. Here we are interested in studying the behavioral effects of these antipsychotic agents in rats with AD disease, and their influence during treatment of these rats with memantine, a NMDA receptor blocker used in management of AD.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version